FDA Authorizes Moderna and Johnson & Johnson Covid-19 Booster And Endorses Mix and Match Strategy
By Radiant HealthPublished: October 24, 2021
Health News Briefs
The FDA authorized Moderna and Johnson & Johnson Covid-19 booster shots. The agency also gave its stamp of approval for the “mix and match” strategy which allows people to boost with a different Covid-19 vaccine than initially received. Those eligible for Moderna booster, administered at least six months after the second dose, include older adults over 65 years as well as younger adults at high risk due to medical conditions or work exposure. All (18 and older) who previously received the J & J vaccine are eligible for booster shots at least two months after their first dose.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- 11 Best Health and Wellness Books to Read in 2024 - July 4, 2024
- Some Americans Will Have Medical Debt Wiped From Credit - July 9, 2022
- Natural Gas Used to Heat Homes Contains Some Harmful Chemicals - July 9, 2022
- Uterine Cancer Claims Many Black Lives - July 9, 2022
- Babies and Toddlers Get COVID-19 Shots - June 27, 2022
- FDA Bans Juul’s E-Cigarettes and Cartridges - June 27, 2022
- Polio Virus Found in London Sewage - June 27, 2022
- 200 Million Americans Are Drinking Contaminated Water - June 19, 2022
- Young Kids Can Finally Get Vaccinated Against COVID-19 - June 19, 2022
- New Regulations for Baby Sleep Products - June 19, 2022